GRAHAM RICHARD A

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
GRAHAM RICHARD A's trades of Theravance Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
50.98
Quantity 43,443
Value US$3,725,408
Transaction date
Proposed sale
Price
9.03
Quantity 2,482
Value US$22,412
Transaction date
Proposed sale
Price
9.89
Quantity 2,482
Value US$24,547
Transaction date
Proposed sale
Price
9.99
Quantity 2,322
Value US$23,197
Transaction date
Proposed sale
Price
9.84
Quantity 2,322
Value US$22,848
Transaction date
Proposed sale
Price
10.69
Quantity 2,322
Value US$24,822
Transaction date
Proposed sale
Price
11.26
Quantity 2,322
Value US$26,146
Transaction date
Proposed sale
Price
11.88
Quantity 2,323
Value US$27,597
Transaction date
Sale
Price
10.73
Quantity 2,084 -0.7%
Value US$22,361
Transaction date
Sale
Price
8.79
Quantity 15,086 -3.9%
Value US$132,606
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-16 2023-11-14
PlS Planned sale
92,421 +37.8%
278.13
US$665,936 		92,421 +37.8% 278.13 US$665,936
2023-11-14 2023-11-14
PrS Proposed sale
43,443
50.98
US$3,725,408 		43,443 50.98 US$3,725,408
2023-10-18 2023-10-16
PlS Planned sale
75,142 -20.9%
155.41
US$2,297,733 		75,142 -20.9% 155.41 US$2,297,733
2023-10-16 2023-10-16
PrS Proposed sale
2,482
9.03
US$22,412 		2,482 9.03 US$22,412
2023-09-18 2023-09-14
PlS Planned sale
2,482 -0.7%
9.89
US$24,547 		2,482 -0.7% 9.89 US$24,547
2023-09-14 2023-09-14
PrS Proposed sale
2,482
9.89
US$24,547 		2,482 9.89 US$24,547
2023-08-15 2023-08-11
PlS Planned sale
2,322 -0.7%
9.99
US$23,197 		2,322 -0.7% 9.99 US$23,197
2023-08-11 2023-08-11
PrS Proposed sale
2,322
9.99
US$23,197 		2,322 9.99 US$23,197
2023-07-18 2023-07-14
PlS Planned sale
2,322 -0.7%
9.84
US$22,848 		2,322 -0.7% 9.84 US$22,848
2023-07-14 2023-07-14
PrS Proposed sale
2,322
9.84
US$22,848 		2,322 9.84 US$22,848
2023-06-16 2023-06-14
PlS Planned sale
2,322 -0.7%
10.69
US$24,822 		2,322 -0.7% 10.69 US$24,822
2023-06-14 2023-06-14
PrS Proposed sale
2,322
10.69
US$24,822 		2,322 10.69 US$24,822
2023-05-17 2023-05-15
PlS Planned sale
2,322 -0.6%
11.26
US$26,146 		2,322 -0.6% 11.26 US$26,146
2023-05-15 2023-05-15
PrS Proposed sale
2,322
11.26
US$26,146 		2,322 11.26 US$26,146
2023-04-18 2023-04-14
PlS Planned sale
2,323 -0.6%
11.88
US$27,597 		2,323 -0.6% 11.88 US$27,597
2023-04-14 2023-04-14
PrS Proposed sale
2,323
11.88
US$27,597 		2,323 11.88 US$27,597
2023-03-16 2023-03-14
PlS Planned sale
2,323 -0.6%
10.32
US$23,973 		2,323 -0.6% 10.32 US$23,973
2023-03-08 2023-03-06
PlS Planned sale
2,323 -0.6%
10.05
US$23,346 		2,323 -0.6% 10.05 US$23,346
2022-12-05 2022-12-01
S Sale
2,084 -0.7%
10.73
US$22,361 		2,084 -0.7% 10.73 US$22,361
2022-08-18 2022-08-16
S Sale
4,906 -1.3%
9.71
US$47,640 		4,906 -1.3% 9.71 US$47,640
2022-08-11 2022-08-09
S Sale
15,086 -3.9%
8.79
US$132,606 		15,086 -3.9% 8.79 US$132,606
2020-12-16 2020-12-14
S Sale
7,500 -5.7%
19.47
US$146,058 		7,500 -5.7% 19.47 US$146,058